Based on these observations and on findings of intact resting and exercise-induced activation of AMPK in skeletal muscle of patients with type 2 diabetes (120, 209, 474), this signifies a potential role of AMPK in skeletal muscle as a pharmacological target for prevention and treatment of inflammation and insulin resistance in various dysmetabolic conditions. This evidence concerns the gene PRKAB1 and type 2 diabetes mellitus.